Cleared Abbreviated

SteadiSet Infusion Set (K242692) - FDA 510(k) Clearance

Class II Chemistry device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K242692 · Capillary Biomedical, LLC · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2025
Decision
242d
Days
Class 2
Risk

K242692 is an FDA 510(k) clearance for the SteadiSet Infusion Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Capillary Biomedical, LLC (Irvine, US). The FDA issued a Cleared decision on May 9, 2025 after a review of 242 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 880.5440 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Capillary Biomedical, LLC devices

Submission Details

510(k) Number K242692 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2024
Decision Date May 09, 2025
Days to Decision 242 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 88d · This submission: 242d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 238
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K242692.
Sparta Infusion Set for Insulin
K243841 · Deka Research and Development · Aug 2025
Infusomat® Space Volumetric Infusion Pump Administration Sets
K243392 · B.Braun Medical, Inc. · Jul 2025
Clave™ Neutral-Displacement Needlefree Connectors
K250616 · Icu Medical, Inc. · Jun 2025
JetCan® Pro Safety Huber Needle
K242763 · Pfm Medical, Inc. · May 2025
Solution Administration Sets
K243529 · Baxter Healthcare Corporation · Mar 2025
Intravascular Extension Sets and Accessories
K242339 · Baxter Healthcare Corporation · Feb 2025